[Treatment of patients with lung cancer with a combination of nitrosomethylurea and cyclophosphane].
Eighty five patients with pulmonary cancer, stage III-IV, were treated with a combination of nitrosomethyl urea and cyclophosphan. In squamous cell cancer a positive objective effect was gained in 35% of patients.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008770:Methylnitrosourea / Q000627:therapeutic use*; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000627:therapeutic use*
D009607:Nitrosourea Compounds; D008770:Methylnitrosourea; D003520:Cyclophosphamide
Lechenie bol'nykh rakom legkogo kombinatsieĭ nitrozometilmocheviny i tsiklofosfana